13F Data
13F filer · CIK 2011385

Catalys Pacific, LLC

Tokyo, M0 · filing since Q4 2023 · last filing Oct 30, 2026
Reported value
$209.7M
$-19.7M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
1 / 1
Turnover
1.2%
buys $2.8M · sells $2.6M
Top-10 weight
100.0%

Biggest buys vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
AddedPhathom Pharmaceuticals, Inc.+388,185+26.0%+$2.8M

Biggest sells vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedMineralys Therapeutics, Inc.-104,320-1.3%$-2.6M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $106.7MQ1 2024: $148.1MQ2 2024: $132.5MQ3 2024: $125.4MQ4 2024: $115.9MQ1 2025: $148.7MQ2 2025: $131.7MQ3 2025: $351.4MQ4 2025: $310.5MQ1 2026: $230.7MQ2 2026: $229.5MQ3 2026: $209.7M
Q4 2023Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1Mineralys Therapeutics, Inc.COM7,799,518$196.0M93.45%
2Phathom Pharmaceuticals, Inc.COM1,882,039$13.7M6.55%